Logotype for DocGo Inc

DocGo (DCGO) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for DocGo Inc

Q3 2024 earnings summary

8 Jul, 2026

Executive summary

  • Q3 2024 revenue was $138.7 million, down about 26% year-over-year due to the planned wind-down of migrant-related projects, but year-to-date revenue rose 17% to $495.7 million.

  • Net income for Q3 2024 was $4.5 million, nearly flat year-over-year; year-to-date net income surged to $21.0 million from $2.1 million in 2023, driven by expanded Mobile Health Services and improved cost management.

  • Adjusted EBITDA for Q3 2024 increased to $17.9 million, with margin improving to 12.9%; year-to-date adjusted EBITDA rose 88% to $59.2 million.

  • Expanded operational footprint with new hubs on the West Coast and Northeast, and care gap closure programs now exceed 500,000 assigned lives, with weekly visits doubling sequentially.

  • Major contract expansions and new program launches with key payers and partners, including L.A. Care and Atlantic City 911 services.

Financial highlights

  • Q3 2024 revenue: $138.7 million (down 25.7% year-over-year); year-to-date: $495.7 million (up 16.6%).

  • Q3 2024 net income: $4.5 million; year-to-date: $21.0 million (up from $2.1 million in 2023).

  • Q3 2024 adjusted EBITDA: $17.9 million; margin: 12.9% (up from 8.9% in Q3 2023).

  • Q3 2024 adjusted gross margin: 36% (up from 29.5% year-over-year); mobile health segment margin at 38.8%, transportation at 30.7%.

  • Cash and equivalents rose to $108.6 million at quarter end, up from $85.8 million in Q2 and $59 million in Q1.

Outlook and guidance

  • 2024 revenue guidance narrowed to $620–$630 million; adjusted EBITDA expected at $70–$75 million; cash flow from operations guidance raised to $90–$100 million.

  • Migrant-related revenue for 2024 expected at $360–$390 million, with base business at $240–$260 million.

  • 2025 consolidated revenue guidance set at $410–$450 million, including $50 million from migrant-related work, with adjusted EBITDA margin projected at 8–10%.

  • Mobile Health Services revenue expected to decline further in Q4 2024 as migrant-related projects wind down, while Transportation Services trip volumes are expected to grow.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more